Melanoma
Article
The power and promise of social media in oncology
Dr. Alan Lyss describes a recent presentation on the role of social media in oncology.
Article
Leveraging the microbiome to enhance cancer treatment
Dr. Alan Lyss reviews research suggesting that an antibiotic can improve the efficacy of radiotherapy.
News
Adverse reactions to immunotherapy can appear after a year
News
Rankings of most common cancers to shift over next 20 years
“It’s time to shift focus to some of the less commonly diagnosed cancers with the lowest survival rates, like pancreatic and liver cancer.”
News
Novel analysis quantifies the benefit of melanoma screening
“Further studies are needed to determine whether individuals without a family history of melanoma may benefit from whole-body screening, and...
News
Don’t delay: Cancer patients need both doses of COVID vaccine
For patients with cancer, immune response to the first dose of the Pfizer COVID-19 vaccine is reduced, and there is a need for a booster dose at...
News
AI detects ugly-duckling skin lesions for melanoma follow-up
Using wide-field photos, a new artificial intelligence program can pick out lesions worthy of follow up for potential melanoma.
Article
How has the pandemic affected rural and urban cancer patients?
News
Checkpoint inhibitors’ ‘big picture’ safety shown with preexisting autoimmune diseases
A Dutch nationwide study in melanoma patients found relative safety of immune checkpoint inhibitors for grade 3 immune-related AEs but does not...
Conference Coverage
Neoadjuvant immunotherapy shows promise in stage III melanoma
There is both preclinical and clinical evidence that neoadjuvant therapy may offer a survival advantage over adjuvant therapy.
